Trial watch: Dendritic cell-based anticancer immunotherapy
/in Dendritic Cells, International Publications /von 2017-05-12 / Oncoimmunology 2017;6(7):e1328341Vaccine-based immunotherapeutic approaches to gliomas and beyond
/in Dendritic Cells, Glioblastoma, International Publications /von 2017-05-12 / Nat Rev Neurol 2017 Jun;13(6):363-374A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
/in Dendritic Cells, Glioblastoma, International Publications /von 2017-05-12 / J Transl Med 2017 05;15(1):104Phase I Trial of Intratumoral Injection of Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8 T-cell Infiltration
/in Dendritic Cells, International Publications, NSCLC /von 2017-05-03 / Clin. Cancer Res. 2017 Aug;23(16):4556-4568Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2017-04-27 / Sci Rep 2017 04;7(1):1217Dendritic cell based vaccination strategy: an evolving paradigm
/in Dendritic Cells, Glioblastoma, International Publications /von 2017-04-22 / J. Neurooncol. 2017 Jun;133(2):223-235Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer
/in Dendritic Cells, Exosome, International Publications, Pancreatic Cancer /von 2017-04-20 / Oncoimmunology 2017;6(6):e1319044Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2017-04-20 / JCI Insight 2017 Apr;2(8)Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2017-04-18 / Oncotarget 2017 Apr;8(16):27252-27262
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de